(Q37079118)

18 August 2017

1 reference

title

Drugs for cardiovascular disease prevention in women: implications of the AHA Guidelines--2007 Update (English)

1 reference

18 August 2017

cardiovascular disease

1 reference

cardiovascular disease in women

inferred from title

0 references

1 reference

1

Nanette K Wenger

1 reference

18 August 2017

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

68

1 reference

18 August 2017

3

1 reference

18 August 2017

339-358

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200868030-00006

18 August 2017

0 references

cites work

Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population

1 reference

12 December 2020

Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure

1 reference

12 December 2020

Combination therapy improves survival after acute myocardial infarction in the elderly with chronic kidney disease

1 reference

12 December 2020

Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate

1 reference

12 December 2020

1 reference

12 December 2020

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Meta-analysis of observational studies on fish intake and coronary heart disease

1 reference

12 December 2020

Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy

1 reference

12 December 2020

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

1 reference

12 December 2020

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

1 reference

12 December 2020

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials

1 reference

12 December 2020

The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy

1 reference

12 December 2020

Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction.

1 reference

12 December 2020

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction

1 reference

12 December 2020

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update

1 reference

12 December 2020

Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts

1 reference

12 December 2020

Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction

1 reference

12 December 2020

Hormone therapy and cardiovascular disease: a systematic review and meta-analysis

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease

1 reference

12 December 2020

Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Drug treatment of hyperlipidemia in women

1 reference

12 December 2020

Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial

1 reference

12 December 2020

How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).

1 reference

12 December 2020

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

1 reference

12 December 2020

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

1 reference

12 December 2020

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

1 reference

12 December 2020

Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial

1 reference

12 December 2020

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr

1 reference

12 December 2020

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

12 December 2020

Homocysteine lowering with folic acid and B vitamins in vascular disease

1 reference

12 December 2020

Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF

1 reference

12 December 2020

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

12 December 2020

Estrogen plus progestin and the risk of coronary heart disease

1 reference

12 December 2020

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

12 December 2020

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

12 December 2020

Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study

1 reference

12 December 2020

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

12 December 2020

Fish oils in the care of coronary heart disease patients: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial

1 reference

12 December 2020

Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport Trials

1 reference

12 December 2020

Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

12 December 2020

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Pharmacotherapy for hypertension in the elderly.

1 reference

12 December 2020

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

12 December 2020

Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction

1 reference

12 December 2020

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention

1 reference

12 December 2020

Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery

1 reference

12 December 2020

Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

12 December 2020

Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I

1 reference

12 December 2020

Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study

1 reference

12 December 2020

Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

12 December 2020

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative

1 reference

12 December 2020

Folate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women

1 reference

12 December 2020

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

12 December 2020

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

12 December 2020

Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study

1 reference

12 December 2020

Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis

1 reference

12 December 2020

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial

1 reference

12 December 2020

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

12 December 2020

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

1 reference

12 December 2020

Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study

1 reference

12 December 2020

Vitamin C and risk of coronary heart disease in women

1 reference

12 December 2020

Folate therapy and in-stent restenosis after coronary stenting

1 reference

12 December 2020

Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure

1 reference

12 December 2020

Homocysteine lowering and cardiovascular events after acute myocardial infarction

1 reference

12 December 2020

Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study

1 reference

12 December 2020

The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy

1 reference

12 December 2020

The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years

1 reference

12 December 2020

Evidence-based guidelines for cardiovascular disease prevention in women

1 reference

12 December 2020

Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men

1 reference

12 December 2020

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial

1 reference

12 December 2020

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

12 December 2020

Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study

1 reference

12 December 2020

Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: results from a randomized trial

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

1 reference

12 December 2020

Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease

1 reference

12 December 2020

Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease

1 reference

12 December 2020

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

12 December 2020

10.2165/00003495-200868030-00006

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18257610